Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
MBX
|
P. Kent Hawryluk
President & CEO |
BUY
Open market or private purchase
|
Indirect | 50,000 Added 0.0% |
$534,500
$10.69 p/Share
|
Feb 04
2025 |
|
CBSH
|
John K Handy
Executive Vice President |
SELL
Open market or private sale
|
Direct | 4,844 Reduced 10.65% |
$325,759
$67.25 p/Share
|
Feb 04
2025 |
|
HGTY
|
Robert I Kauffman
Director |
SELL
Open market or private sale
|
Indirect | 6,165 Reduced 0.0% |
$60,663
$9.84 p/Share
|
Feb 04
2025 |
|
ROLL
|
Daniel A Bergeron
Vice President and COO |
SELL
Open market or private sale
|
Direct | 17,500 Reduced 13.58% |
$6,395,375
$365.45 p/Share
|
Feb 04
2025 |
|
HBT
|
Fred L Drake
Executive Chairman |
SELL
Open market or private sale
|
Indirect | 9,945 Reduced 0.0% |
$244,547
$24.59 p/Share
|
Feb 04
2025 |
|
ROLL
|
Dolores J Ennico |
SELL
Open market or private sale
|
Direct | 1,400 Reduced 18.0% |
$514,388
$367.42 p/Share
|
Feb 04
2025 |
|
CHWY
|
Sumit Singh
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 57,337 Reduced 5.78% |
$2,176,512
$37.96 p/Share
|
Feb 04
2025 |
|
CHWY
|
Sumit Singh
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 5,158 Reduced 0.0% |
$195,797
$37.96 p/Share
|
Feb 04
2025 |
|
CBSH
|
Derrick Brooks
Senior Vice President |
SELL
Open market or private sale
|
Direct | 175 Reduced 1.25% |
$11,700
$66.86 p/Share
|
Feb 04
2025 |
|
CHWY
|
Satish Mehta
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 11,645 Reduced 2.67% |
$442,044
$37.96 p/Share
|
Feb 04
2025 |
|
MBWM
|
Nelson F Sanchez |
BUY
Open market or private purchase
|
Indirect | 189 Added 0.0% |
$8,977
$47.5 p/Share
|
Feb 04
2025 |
|
CHWY
|
David Reeder
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 53,931 Reduced 11.5% |
$2,047,220
$37.96 p/Share
|
Feb 04
2025 |
|
SO
|
Christopher Cummiskey
EVP |
SELL
Open market or private sale
|
Direct | 837 Reduced 3.59% |
$69,738
$83.32 p/Share
|
Feb 04
2025 |
|
ABUS
|
J. Christopher Naftzger
General Counsel and CCO |
SELL
Open market or private sale
|
Direct | 11,333 Reduced 11.61% |
$37,172
$3.28 p/Share
|
Feb 04
2025 |
|
ABUS
|
Michael J. Mc Elhaugh
Interim President & CEO |
SELL
Open market or private sale
|
Direct | 23,790 Reduced 1.58% |
$78,031
$3.28 p/Share
|
Feb 04
2025 |
|
ABUS
|
Karen Sims
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 19,348 Reduced 15.41% |
$63,461
$3.28 p/Share
|
Feb 04
2025 |
|
ABUS
|
David C Hastings
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 22,183 Reduced 12.19% |
$72,760
$3.28 p/Share
|
Feb 04
2025 |
|
LII
|
John D Torres
Executive Vice President |
SELL
Open market or private sale
|
Direct | 1,787 Reduced 35.34% |
$1,041,588
$582.87 p/Share
|
Feb 04
2025 |
|
HWBK
|
Jonathan Holtaway
Director |
SELL
Open market or private sale
|
Indirect | 3,707 Reduced 0.0% |
$121,960
$32.9 p/Share
|
Feb 04
2025 |
|
VIAV
|
Keith Barnes
Director |
SELL
Open market or private sale
|
Direct | 15,418 Reduced 7.94% |
$188,716
$12.24 p/Share
|
Feb 04
2025 |
|
VIAV
|
Paul Mc Nab
EVP, Chief Mktg & Stgy Officer |
SELL
Open market or private sale
|
Direct | 4,930 Reduced 12.85% |
$60,096
$12.19 p/Share
|
Feb 04
2025 |
|
CLXT
|
Gerhard Prante
Director |
SELL
Open market or private sale
|
Direct | 1,150 Reduced 4.4% |
$2,817
$2.45 p/Share
|
Feb 04
2025 |
|
CBNA
|
Michael J. Conover
Director |
BUY
Open market or private purchase
|
Direct | 300 Added 8.45% |
$7,383
$24.61 p/Share
|
Feb 04
2025 |
|
NXL
|
David Owens
Chief Medical Officer |
BUY
Open market or private purchase
|
Direct | 1,000 Added 0.64% |
$3,100
$3.1 p/Share
|
Feb 04
2025 |
|
OSIS
|
Deepak Chopra
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 5.2% |
$3,965,200
$198.26 p/Share
|
Feb 04
2025 |
|
TER
|
Sanjay Mehta
VP and Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,384 Reduced 3.65% |
$154,302
$111.49 p/Share
|
Feb 04
2025 |
|
TER
|
Richard John Burns
President, Semiconductor Test |
SELL
Open market or private sale
|
Direct | 445 Reduced 1.74% |
$49,613
$111.49 p/Share
|
Feb 04
2025 |
|
TER
|
Ryan Driscoll
VP, General Counsel, Secretary |
SELL
Open market or private sale
|
Direct | 216 Reduced 2.99% |
$24,081
$111.49 p/Share
|
Feb 04
2025 |
|
MPB
|
Matthew G De Soto
Director |
BUY
Open market or private purchase
|
Indirect | 1,035 Added 0.0% |
$29,859
$28.85 p/Share
|
Feb 04
2025 |
|
MPB
|
Matthew G De Soto
Director |
BUY
Open market or private purchase
|
Direct | 2,575 Added 2.44% |
$74,752
$29.03 p/Share
|
Feb 04
2025 |
|
CAT
|
Gerald Johnson
Director |
BUY
Open market or private purchase
|
Direct | 100 Added 3.17% |
$36,557
$365.57 p/Share
|
Feb 04
2025 |
|
XOM
|
Darrin L Talley
VP - Corp Strategic Planning |
SELL
Open market or private sale
|
Indirect | 2,100 Reduced 0.0% |
$231,000
$110.0 p/Share
|
Feb 04
2025 |
|
BR
|
Laura Matlin
CVP, Deputy GC and CCO |
SELL
Open market or private sale
|
Direct | 514 Reduced 7.22% |
$124,182
$241.6 p/Share
|
Feb 04
2025 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 912 Added 0.0% |
$2,553
$2.8 p/Share
|
Feb 04
2025 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Direct | 328 Added 0.58% |
$918
$2.8 p/Share
|
Feb 04
2025 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1 Added 0.0% |
$1,361
$1361.19 p/Share
|
Feb 04
2025 |
|
ACCD
|
Robert N Cavanaugh
President |
SELL
Open market or private sale
|
Direct | 557 Reduced 0.26% |
$3,860
$6.93 p/Share
|
Feb 04
2025 |
|
ACCD
|
Stephen H. Barnes
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 448 Reduced 0.15% |
$3,104
$6.93 p/Share
|
Feb 04
2025 |
|
HQL
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,065 Reduced 0.0% |
$57,113
$14.05 p/Share
|
Feb 04
2025 |
|
ACCD
|
Richard Eskew
EVP General Counsel |
SELL
Open market or private sale
|
Direct | 390 Reduced 0.61% |
$2,702
$6.93 p/Share
|
Feb 04
2025 |
|
ACCD
|
Rajeev Singh
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,170 Reduced 0.14% |
$8,108
$6.93 p/Share
|
Feb 04
2025 |
|
NXJ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 37,303 Reduced 0.0% |
$452,858
$12.14 p/Share
|
Feb 04
2025 |
|
BXP
|
Hilary J. Spann
Executive Vice President |
SELL
Open market or private sale
|
Direct | 12,379 Reduced 63.0% |
$891,535
$72.02 p/Share
|
Feb 04
2025 |
|
BCAT
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 25,108 Reduced 0.0% |
$390,429
$15.55 p/Share
|
Feb 04
2025 |
|
MPA
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 5,758 Reduced 0.0% |
$68,347
$11.87 p/Share
|
Feb 04
2025 |
|
BFZ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 45,609 Reduced 0.0% |
$514,925
$11.29 p/Share
|
Feb 04
2025 |
|
ISSC
|
Christopher Harborne
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 63,368 Reduced 0.0% |
$710,355
$11.21 p/Share
|
Feb 04
2025 |
|
PKBK
|
Jeffrey H Kripitz
Director |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 11.04% |
$151,425
$20.19 p/Share
|
Feb 04
2025 |
|
TKO
|
Patrick Whitesell |
BUY
Open market or private purchase
|
Indirect | 76,587 Added 0.0% |
$12,081,599
$157.75 p/Share
|
Feb 04
2025 |
|
TKO
|
Ariel Emanuel
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 76,587 Added 0.0% |
$12,081,599
$157.75 p/Share
|
Feb 04
2025 |